Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–7.

Article  PubMed  Google Scholar 

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42.

Article  PubMed  Google Scholar 

Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–17.

Article  PubMed  Google Scholar 

Danese S, Fiocchi C. Ulcerative colitis. N. Engl J Med. 2011;365:1713–25.

Article  CAS  PubMed  Google Scholar 

Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590–605.

Article  PubMed  Google Scholar 

Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–42.

Article  CAS  PubMed  Google Scholar 

Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vereecke L, Beyaert R, van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med. 2011;17:584–93.

Article  CAS  PubMed  Google Scholar 

Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343:1249288.

Article  PubMed  PubMed Central  Google Scholar 

Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54–61.

Article  CAS  PubMed  Google Scholar 

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145–9.

Article  CAS  PubMed  Google Scholar 

Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306.

Article  CAS  PubMed  Google Scholar 

Lyu M, Suzuki H, Kang L, Gaspal F, Zhou W, Goc J, et al. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. Nature. 2022;610:744–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kedmi R, Najar TA, Mesa KR, Grayson A, Kroehling L, Hao Y, et al. A RORgammat(+) cell instructs gut microbiota-specific T(reg) cell differentiation. Nature. 2022;610:737–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Doty AL, Tang Y, Berrie D, Iqbal A, Tan SA, et al. Enrichment of IL-17A(+) IFN-gamma(+) and IL-22(+) IFN-gamma(+) T-cell subsets is associated with reduction of NKp44(+) ILC3s in the terminal ileum of Crohn’s disease patients. Clin Exp Immunol. 2017;190:143–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin JC, Chang C, Boschetti G, Ungaro R, Giri M, Grout JA, et al. Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493–1508 e1420.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science. 2015;348:1031–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature. 2019;568:405–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou L, Zhou W, Joseph AM, Chu C, Putzel GG, Fang B, et al. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation. Nat Immunol. 2022;23:251–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldberg R, Prescott N, Lord GM, MacDonald TT, Powell N. The unusual suspects-innate lymphoid cells as novel therapeutic targets in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:271–83.

Article  CAS  PubMed  Google Scholar 

He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997;90:739–51.

Article  CAS  PubMed  Google Scholar 

Takagi S, Kasuya Y, Shimizu M, Matsuura T, Tsuboi M, Kawakami A, et al. Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. Dev Biol. 1995;170:207–22.

Article  CAS  PubMed  Google Scholar 

Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell. 1997;90:753–62.

Article  CAS  PubMed  Google Scholar 

Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735–45.

Article  CAS  PubMed  Google Scholar 

Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004;34:623–30.

Article  CAS  PubMed  Google Scholar 

Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, et al. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature. 2013;501:252–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leclerc M, Voilin E, Gros G, Corgnac S, de Montpréville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Somasundaram A, Manne S, Gocher AM, Szymczak-Workman AL, Vignali KM, et al. Neuropilin-1 is a T-cell memory checkpoint limiting long-term antitumor immunity. Nat Immunol. 2020;21:1010–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Qiu J, Zhou W, Cao J, Hu X, Mi W, et al. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat Immunol. 2022;23:237–50.

Article  PubMed  Google Scholar 

Zheng, X. et al. Neuropilin-1(high) monocytes protect against neonatal inflammation. Cell Mol Immunol. 2024;21:575–88.

Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, et al. Ulcerative colitis mucosal transcriptomes reve